pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
Approval · news · pharmadog
← back to Approval
News · Approval
642
stories
11d
Silence brings the noise to Takeda with phase 2 blood cancer win
fiercebiotech
11d
Biogen’s targeted ALS treatment is reversing decline in some patients. Can more be helped?
biospace
11d
As BMS’ Cobenfy struggles to gain traction, MapLight knocks on the door
biospace
11d
Psychedelics on the cusp of market breakthrough as clinical, policy support grow
biospace
11d
Recon: BMS plans $2.3B Houston manufacturing site; MHRA approves Lilly weight-loss drug for weight loss, type 2 diabetes
raps
13d
FDA to hold adcomm for Grail cancer test that failed in large, randomized trial
endpoints
14d
Replimune to ride wave of physician support to launch advanced melanoma therapy
biospace
14d
STAT+: Pharmalittle: We’re reading about Replimune’s melanoma drug, a Medicare policy change, and more
stat
14d
Is the biotech capital of the world moving?
stat
14d
Latigo IPO raises nearly $350M for pain drug development
biopharma dive
14d
BlossomHill, Latigo outshine IPO expectations with oversubscribed debuts
fiercebiotech
14d
This Week at FDA: Inspection reorg, acting CBER chief eyes IND reforms, and more
raps
14d
Replimune rebounds to win FDA approval of melanoma drug
biopharma dive
14d
Third time’s the charm for Replimune as melanoma drug earns FDA greenlight
biospace
14d
Replimune wins FDA approval after melanoma drug was twice rejected
endpoints
14d
STAT+: FDA approves Replimune melanoma drug previously rejected twice
stat
14d
FDA Approves New Engineered Viral Immunotherapy for Patients with Treatment-Resistant Advanced Melanoma
fda press
14d
Alkeus, an unorthodox eye drug startup, acquired by Tarsus for up to $800M
biopharma dive
14d
Takeda approval ushers in new wave of sleep drugs
biopharma dive
15d
STAT+: Two FDA approvals — a new drug and a new vaccine
stat
15d
Takeda’s narcolepsy nod opens orexin doors
biospace
15d
STAT+: Pharmalittle: We’re reading about Moderna’s flu shot, a death in a gene-editing trial in China, and more
stat
15d
Sanofi pauses mid-stage lung study amid new CEO’s ‘rigorous portfolio prioritization’
biospace
15d
Opinion: One year since Kennedy canceled mRNA vaccine projects, science shows how wrong he was
stat
15d
Covid can reactivate dormant viruses, according to study
stat
15d
Moderna’s flu shot crosses FDA finish line, bouncing back from regulatory roadblock
biospace
15d
FDA approves Moderna’s mRNA flu vaccine
biopharma dive
15d
Double shot of Vistagen’s anxiety nasal spray can’t beat placebo in ph. 2 trial
fiercebiotech
15d
FDA approves Moderna flu vaccine after spat with past agency leaders
endpoints
15d
FDA approves Moderna’s mRNA flu vaccine, the first to use the technology
stat
← prev
page 5 of 22
next →
